M&T Bank
LXRX icon

M&T Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

M&T Bank’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,407
Closed -$103K – 1640
2019
Q2 		$103K Buy
16,407
+4,634
+39% +$27.7K ﹤0.01% 1497
2019
Q1 		$66K Buy
+11,773
New +$71.5K ﹤0.01% 1511
2015
Q2 		– Sell
-10,371
Closed -$69K – 2156
2015
Q1 		$69K Hold
10,371
– – ﹤0.01% 1875
2014
Q4 		$66K Buy
10,371
+5,337
+106% +$43K ﹤0.01% 1907
2014
Q3 		$49K Buy
+5,034
New +$53.8K ﹤0.01% 2087

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

M&T Bank's LXRX Position: Q3 2019 in Review

M&T Bank sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2019, closing a stake of 16,407 shares — an estimated $103K sold.

M&T Bank first reported a position in LXRX in Q3 2014 and held it in 5 quarters. The position peaked at $103K in Q2 2019. 103 funds tracked by Wall St. Rank hold LXRX as of Q3 2019.

  • M&T Bank reported no remaining Lexicon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • M&T Bank sold 16,407 Lexicon Pharmaceuticals shares in Q3 2019, an estimated $103K.
  • M&T Bank first reported a position in Lexicon Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • M&T Bank's Lexicon Pharmaceuticals position peaked at $103K in Q2 2019.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2019.

Based on M&T Bank's 13F filing for Q3 2019, filed 12 Nov 2019.